Profile
Sector:
HealthcareIndustry:
Medical Care FacilitiesCountry:
United KingdomIPO:
18 September 2020Website:
http://compasspathways.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | 6 min agoDividend
Analysts recommendations
Institutional Ownership
CMPS Latest News
Jason Najum covers the psychedelic space and contextualizes recent news around the FDA, MDMA, PTSD, and Lykos Therapeutics. Why it may be a blessing in disguise for Cybin, COMPASS Pathways, and MindMed despite setbacks.
COMPASS Pathways plc (NASDAQ:CMPS ) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Guy Goodwin - Chief Medical Officer Teri Loxam - CFO Conference Call Participants Ritu Baral - TD Cowen Leonid Timashev - RBC Capital Markets Charles Duncan - Cantor Vikram Purohit - Morgan Stanley Gavin Clark-Gartner - Evercore ISI Sumant Kulkarni - Canaccord Genuity Tom Shrader - BTIG Elemer Piros - Rodman Operator Good day, ladies and gentlemen, and welcome to COMPASS Pathways' Second Quarter 2024 Conference Call. [Operator Instructions] As a reminder, this call is being recorded.
Compass Pathways plc, a biotechnology company focused on improving patient access to evidence-based mental health solutions, will report its financial results for the first quarter of 2024 and share recent business updates on May 8, 2024.
There are some great microcap stocks for investors to scoop up this month. The broader indices, such as the S&P 500 and the Nasdaq, are showing signs of both strength and weakness, but I believe that there's still a lot of gas left in the tank for these to surge higher.
LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference at 12:50 pm ET on March 4, 2024.
LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference at 2:00 pm ET on February 13, 2024.
Critical catalysts are approaching in the psychedelic sector, with the potential for the first FDA-approved psychedelic therapy by the end of the year.
COMPASS Pathways plc (NASDAQ:CMPS ) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Mary-Rose Hughes - Interim CFO Dr. Guy Goodwin - Chief Medical Officer Conference Call Participants Ritu Baral - TD Cohen Charles Duncan - Cantor François Brisebois - Oppenheimer Patrick Trucchio - H.C. Wainright Michael Okunewitch - Maxim Group Sumant Kulkarni - Canaccord Genuity Gavin Clark-Gartner - Evercore ISI Thomas Shrader - BTIG Operator Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Third Quarter 2023 Conference Call.
LONDON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter 2023, and provide an update on recent business developments on November 2, 2023.
Psychedelic stocks are on the rise. Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness for treating a variety of conditions.
- 1(current)
What type of business is COMPASS Pathways?
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
What sector is COMPASS Pathways in?
COMPASS Pathways is in the Healthcare sector
What industry is COMPASS Pathways in?
COMPASS Pathways is in the Medical Care Facilities industry
What country is COMPASS Pathways from?
COMPASS Pathways is headquartered in United Kingdom
When did COMPASS Pathways go public?
COMPASS Pathways initial public offering (IPO) was on 18 September 2020
What is COMPASS Pathways website?
https://compasspathways.com
Is COMPASS Pathways in the S&P 500?
No, COMPASS Pathways is not included in the S&P 500 index
Is COMPASS Pathways in the NASDAQ 100?
No, COMPASS Pathways is not included in the NASDAQ 100 index
Is COMPASS Pathways in the Dow Jones?
No, COMPASS Pathways is not included in the Dow Jones index
When was COMPASS Pathways the previous earnings report?
No data
When does COMPASS Pathways earnings report?
The next expected earnings date for COMPASS Pathways is 28 February 2025